ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
40.71
-0.78%
US Tech 100
21,524.40
0.41%
S&P 500
6,114.63
-0.01%
US Dollar vs CAD
1.41741
-0.11%
Bitcoin
96,400.53
0.25%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. Europe
  5. EU

  6. SideTrade (ALBFR) Share Price

SideTrade

SideTrade (ALBFR)

EU
252.00
0.00
(0.00%)
Closed February 17 10:30AM
Delayed by 15 minutes

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Key stats and details

Current Price
252.00
Bid
252.00
Ask
254.00
Volume
0.00
0.00 Day's Range 0.00
148.50 52 Week Range 271.00
Market Cap
369.917M
Previous Close
252.00
Open
-
Last Trade
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
1,141
Shares Outstanding
1,467,926
Dividend Yield
-
PE Ratio
65.75
Earnings Per Share (EPS)
3.83
Revenue
48.58M
Net Profit
5.63M

About SideTrade

Sector
Prepackaged Software
Industry
Prepackaged Software
Website
www.sidetrade.com
Headquarters
Boulogne-billancourt, Hauts-de-seine, Fra
Founded
-
SideTrade is listed in the Prepackaged Software sector of the Euronext with ticker ALBFR. The last closing price for SideTrade was 252.00 €. Over the last year, SideTrade shares have traded in a share price range of 148.50 € to 271.00 €.

SideTrade currently has 1,467,926 shares outstanding. The market capitalization of SideTrade is 369.92 € million. SideTrade has a price to earnings ratio (PE ratio) of 65.75.

Ask ADVFN Intelligence (AI)

ALBFR Latest News

More News
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-3-1.176470588242552652481731257.55472091DE
42511.0132158592272712271393254.17570802DE
122511.013215859227271195.51141235.46565832DE
264320.57416267942092711921088226.50183051DE
5291.557.0093457944160.5271148.5911205.53456121DE
156112801402710.2750166.39777949DE
260184270.588235294682710.21039141.83674552DE

ALBFR - Frequently Asked Questions (FAQ)

What is the current SideTrade share price?
The current share price of SideTrade is 252.00 €
How many SideTrade shares are in issue?
SideTrade has 1,467,926 shares in issue
What is the market cap of SideTrade?
The market capitalisation of SideTrade is EUR 369.92M
What is the 1 year trading range for SideTrade share price?
SideTrade has traded in the range of 148.50 € to 271.00 € during the past year
What is the PE ratio of SideTrade?
The price to earnings ratio of SideTrade is 65.75
What is the cash to sales ratio of SideTrade?
The cash to sales ratio of SideTrade is 7.62
What is the reporting currency for SideTrade?
SideTrade reports financial results in EUR
What is the latest annual turnover for SideTrade?
The latest annual turnover of SideTrade is EUR 48.58M
What is the latest annual profit for SideTrade?
The latest annual profit of SideTrade is EUR 5.63M
What is the registered address of SideTrade?
The registered address for SideTrade is 114 RUE GALLIENI, BOULOGNE-BILLANCOURT, HAUTS-DE-SEINE, 92100
What is the SideTrade website address?
The website address for SideTrade is www.sidetrade.com
Which industry sector does SideTrade operate in?
SideTrade operates in the PREPACKAGED SOFTWARE sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
ABCAABC Arbitrage
5.31 €
(0.00%)
0
ABAb Science
1.52 €
(0.00%)
0
AALBAalberts NV
36.00 €
(0.00%)
0
AAAAlan Allman Associates
4.68 €
(0.00%)
0
74SW74Software SA
27.60 €
(0.00%)
0
ABCAABC Arbitrage
5.31 €
(0.00%)
0
ABAb Science
1.52 €
(0.00%)
0
AALBAalberts NV
36.00 €
(0.00%)
0
AAAAlan Allman Associates
4.68 €
(0.00%)
0
74SW74Software SA
27.60 €
(0.00%)
0
ABCAABC Arbitrage
5.31 €
(0.00%)
0
ABAb Science
1.52 €
(0.00%)
0
AALBAalberts NV
36.00 €
(0.00%)
0
AAAAlan Allman Associates
4.68 €
(0.00%)
0
74SW74Software SA
27.60 €
(0.00%)
0

Discussion

View Full Feed
NeoSunTzu NeoSunTzu 3 minutes ago
He will sign off on any sensible plan that his trusted delegates bring to him WITHOUT picking at the details if he trusts them and they present their plan in a favorable light - he simply has too many things to deal with to nitpick at details UNLESS there is an obvious sign that something is NOT rig
Hoghead7 Hoghead7 9 minutes ago
Feasel speaking at NJ energy coalition in March
https://www.linkedin.com/posts/erick-ford-60530113_coming-march-11th-2025-another-great-event-activity-7297053390952357888-4QH7?utm_source=share&utm_medium=member_android&rcm=ACoAAD0kMAgBCjdlnBi58ae16C413y05wUfF-9o
FCEL
ValueX ValueX 16 minutes ago
The financial volume in the range of $200-500 per day does not tell me much. At the moment only small traders. Let's see if there will be an increase in interest in the coming days .
At the moment I am skeptical 😎
AVVH
fink fink 21 minutes ago
I had to stop reading after the first sentence,
When he used the word "raid" that said it all.

They are not raiding anything. They are auditing the department and we all know the SEC is so on the up and up.

Let's see what they find. USAID was an eye opener. I k
IGPK
newmedman newmedman 21 minutes ago
that thought did cross my mind but I'm supposed to be a libtard. My boobs aren't that much but I'll die laughing if he posts me back
ElementalArcher25 ElementalArcher25 23 minutes ago
I agree. I want the best price possible but if Naz can get an offer of 3 or more I would good with that but under 2 I would say wait but that's just mho.
ELTP
jour_trader jour_trader 28 minutes ago
Not necessarily. If R&D pipeline really is robust, we need time to execute. R&D pre-FDA filing isn't worth more than an FDA filing, which is less than an approved and launched product. R&D formulation lately has been slow to move due to all of the recent product launches, which is the reason to look
ELTP
janice shell janice shell 29 minutes ago
Yes? What "fraud" and "theft" have Musk and his proteges found? What they've bragged about finding?

Where's the proof? No one's seen any.
shurtha2000 shurtha2000 30 minutes ago
I'm expecting Fort Knox Audit to come up on a lot of missing gold -what happens to the price ? $$
Preciouslife1 Preciouslife1 31 minutes ago
https://www.mlb.com/news/giancarlo-stanton-dealing-with-sore-elbows-at-yankees-spring-training
silkmaster silkmaster 31 minutes ago
Well i hope that you will be able to change that target from 2029 back to 2025. based on news from KT and lab.

Less R&D news , yes the world of science will love it and it could help the share value years from now , but i think investors that are in Lt care less by now of what happe
KBLB
Whalatane Whalatane 32 minutes ago
Yes, the approval for a share buyback can expire, depending on the jurisdiction and the specific terms set by the company or its governing body.

United States: In the U.S., share buyback programs authorized by a company's board of directors typically do not have a statutory expiration
AMRN
ElementalArcher25 ElementalArcher25 32 minutes ago
Just remember the old saying a bird in the hand is better than 2 in the bush
ELTP
Preciouslife1 Preciouslife1 34 minutes ago
https://www.mlb.com/news/starling-marte-ready-to-contribute-for-mets-in-2025
jour_trader jour_trader 35 minutes ago
Likely the same result as Adderall IR & ER that were already crowded when Elite entered the market. We earned significant marketshare...
ELTP
jealmc79 jealmc79 38 minutes ago
" style="caret-color: rgb(29, 38, 46); color: rgba(29, 38, 46, 1); font-family: DMSans-Regular, sans-serif; font-size: 15px".i think they were built in Lam Dong..."
style="caret-color: rgb(29, 38, 46); color: rgba(29, 38, 46, 1); font-family: DMSans-Regular, sans-serif; font-size: 15p
KBLB
ElementalArcher25 ElementalArcher25 38 minutes ago
Yeah great ideal and what happens if 10 other generic drug makers get approved to manufacture Vyvanse over the next year?
ELTP
OMOLIVES OMOLIVES 40 minutes ago
Not sure...but these expenses are just being credited to the purchase price anyhow ;)
HMBL
newmedman newmedman 43 minutes ago
oh, coho is the tastiest fish I ever had. We cut the steaks up from the whale and they just don't shrink. It's seriously good fish. There's nothing else like it in my book, but I'm a bit of a homer. Waukegan harbor and I know each other very well.
asp42001 asp42001 43 minutes ago
Government E2E EBPP&H Common Sense!

USIO could help process, handle & verify government spending!

Follow digital money-trails, cut expenses...WIN-Win!

DEAL!
USIO
getmenews getmenews 43 minutes ago
Interesting, Japan been accumulating XRP, now they want to offer ETF's, wonder if Japan will unload once it's approved, which it shouldn't be unless it's traded as a security! HMM

Robinhood didn't allow traders to buy at .50, now traders can trade it again at 2.50? HMM

XRPUSD
norisknorewards norisknorewards 47 minutes ago
Must be a sign of the bottom if ya ask me based on this posters history

Exciting
NWBO
janice shell janice shell 49 minutes ago
That would be generally helpful. Yes, his work on EVs has been interesting, but hardly problem-free. The same can be said of SpaceX.

The work can be carried on by people who are not drama queens.

Your Recent History

EU
ALBFR
SideTrade
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads